Oncology

Latest News

Doctor carrying documentation for patient care | image credit: Kanisorn - stock.adobe.com.jpeg

NCODA Outlines New Patient-Centered Oncology Distribution Models

By Pearl Steinzor

May 1st 2025

Experts champion medically integrated care and oncology optimized distribution models as vital strategies to improve outcomes, streamline access, and reduce costs for patients.

The thinking around which patients are eligible for liver transplants needs to evolve, the authors noted, as the criteria used to evaluate fitness for transplant were proposed nearly three decades ago. | Image credit: Peakstock - stock.adobe.com

New Developments Warrant Rethinking HCC Transplant Criteria

By Jared Kaltwasser

April 29th 2025

Women with fatigue | Image credit: Adobe Stock

Fatigue, Depression Hit Harder on Women Cancer Survivors, Data Show

By Mary Caffrey

April 29th 2025

senior scientist | Image credit: Ohio State University

Proving the Concept: A Sampler of Early-Stage Science at AACR 2025

By Mary Caffrey

April 28th 2025

NSCLC | Image: Lung Cancer Foundation of America

Zongertinib Shows Durable Responses With No Interstitial Lung Disease in HER2-Mutated Advanced NSCLC

By Mary Caffrey
Brooke McCormick

April 28th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

October 1st 2015

Cancer Survivor Clinics Can Reduce ED Utilization, Study Shows

Surabhi Dangi-Garimella, PhD

A government-funded network of specialized survivor clinics in Ontario, Canada, significantly decreased emergency department visits among adult survivors of childhood cancer.

October 1st 2015

WISDOM Study Aims to Personalize Breast Cancer Screening

The study plans to evaluate the impact of a personalized approach to breast cancer screening over an annual mammogram.

October 1st 2015

Opdivo-Yervoy Combination Approved for Metastatic Melanoma Harboring Wild-Type BRAF

Surabhi Dangi-Garimella, PhD

This approval marks the first-ever for 2 immuno-oncology agents in cancer treatment.

September 30th 2015

A Breast Cancer Risk Assessment Tool That Includes Breast Density Measures

Surabhi Dangi-Garimella, PhD

The result of a multicollaborative effort, the study published in the Journal of Clinical Oncology found that incorporating breast density information in the risk calculator could accurately estimate women's risk for the disease.

September 30th 2015

Reply to "Transforming Oncology Care": Advancing Value, Accessing Innovation

Rebecca Paradis, MPA

Patient access to innovation may be at risk as new payment models emerge in oncology.

September 30th 2015

Public Strongly Favors Medicare Funding for End-of-Life Talks, Poll Finds

Mary K. Caffrey

The findings come as CMS is poised to finalize a rule to pay doctors to counsel patients about end-of-life treatment options.

September 30th 2015

Conflict of Interest Rampant in Academic-Industry Partnerships

Surabhi Dangi-Garimella, PhD

A study published in BMJ measured the prevalence, annual compensation, and beneficial stock ownership of directors from publicly traded healthcare companies who had academic affiliations.

September 29th 2015

ECC Data Recommends Fewer but Stronger Doses of Radiation for Prostate Tumors

The CHHiP trial found fewer high-dose radiotherapy was as effective as more number of low-dose radiotherapy in men with prostate cancer.

September 29th 2015

CAD Increases Cost and May Even Miss Detecting Breast Cancers, Says BCSC Study

Surabhi Dangi-Garimella, PhD

An NCI-funded Breast Cancer Surveillance Consortium study has found that computer-aided detection and interpretation of mammograms does not add any value to breast cancer screening.

September 29th 2015

The Patient Will See You Now: Part 1

My visit to the gynecologist's office following treatment for breast cancer and a subsequent reconstructive surgery was a rude awakening.

September 28th 2015

Results of Gene Panel Test Can Determine Need for Chemotherapy in Breast Cancer

Surabhi Dangi-Garimella, PhD

A prospective study that enrolled more than 10,000 women with hormone-receptor—positive, HER2-negative breast cancer has found that their response to a 21-gene test can identify patients who can avoid chemotherapy.

Dr Amy Davidoff Highlights the Benefits of Palliative Care, Discusses Biosimilars

September 28th 2015

Dr Amy Davidoff Highlights the Benefits of Palliative Care, Discusses Biosimilars

Palliative care should enter into the discussion with patients with cancer as early as possible as it can manage symptoms from therapy or it can provide comfort to patients who cannot afford or choose to forgo therapy, said Amy Davidoff, PhD, MS. Plus, she discusses the impact biosimilars may have on therapy costs.

September 28th 2015

Distinct Molecular Tumor Profile in Younger CRC Patients Recognized

Surabhi Dangi-Garimella, PhD

Data presented at the ongoing European Cancer Congress has identified a different epigenetic profile in the tumors of younger colorectal cancer patients, information that can help improve treatment options in this population.

Dr Ira Klein Discusses the Use of Fee-for-Service in Oncology

September 27th 2015

Dr Ira Klein Discusses the Use of Fee-for-Service in Oncology

Although CMS has introduced a strict timeline to move to value-based payments, its new Oncology Care Model is partially relying on fee-for-service, and that's a good thing in the case of oncology, said Ira Klein, MD, MBA, senior director of quality, Strategic Customer Group at The Janssen Pharmaceutical Companies of Johnson & Johnson.

This Week in Managed Care: September 26, 2015

September 26th 2015

This Week in Managed Care: September 26, 2015

Top managed care stories this week include the follow up to the National Academy of Medicine's groundbreaking "To Err Is Human" report, findings on the sharp increase in deductibles, and discussing costs in cancer care.

September 25th 2015

First-Ever Therapeutic HPV Vaccine Promising Against Cervical Cancer

Surabhi Dangi-Garimella, PhD

Developed by Inovio Pharmaceuticals, the vaccine has shown the potential to impact precancerous cervical lesions.

September 25th 2015

Results at ESMO Focus on Companion Diagnostics, Avoiding Overtreatment in Prostate Cancer

Posters focus on next-generation sequencing ovarian cancer and identify candidates for treatment with PARP inhibitors.

September 25th 2015

Molecularly Targeted SHIVA Trial Fails to Improve Outcomes in Refractory Cancer Patients

Surabhi Dangi-Garimella, PhD

The trial, conducted in France, was a proof-of-concept study to evaluate the efficacy of targeted agents in patients, based on their tumor's molecular profile.

September 25th 2015

The Dawning of Democratized Cancer Care

Emmanuel F. Petricoin III, PhD

Innovative trials offer the promise that patients can be treated in their own communities instead of traveling to faraway cancer centers.

September 24th 2015

Startup's Direct-to-Consumer Genetic Test Receives FDA Attention

Surabhi Dangi-Garimella, PhD

In a letter to Pathway Genomics, the FDA has expressed interest in discussing the company's validation strategy as well as evaluating data on clinical sensitivity and specificity of the CancerIntercept Detect test.

September 24th 2015

ASCO President Julie Vose, MD, to Give Keynote at AJMC's Patient-Centered Oncology Care Meeting

The fourth annual meeting of Patient-Centered Oncology Care, set for November 19-20, 2015, in Baltimore, Maryland, will feature a premiere multi-stakeholder lineup where leading payers, providers, and leaders from pharma will discuss how to deliver value-based care as cost of breakthrough therapies continues to climb. Julie Vose, MD, MBA, FASCO, the president of the American Society of Clinical Oncology, will give the keynote address.

September 24th 2015

USPSTF Recommendation May Increase Risk for Prostate Cancer

Surabhi Dangi-Garimella, PhD

A study published in The Journal of Urology suggests the Grade D recommendation for PSA-based screening may place those with intermediate and high-risk prostate cancer at risk.

Dr Julie Vose on the Importance of Attending PCOC15

September 23rd 2015

Dr Julie Vose on the Importance of Attending PCOC15

Julie Vose, MD, MBA, FASCO, president of the American Society of Clinical Oncology and keynote speaker at Patient-Centered Oncology Care 2015, explains the importance of the meeting and how patients benefit when a diverse set of stakeholders come together in one room.

September 23rd 2015

Dissecting the Patient Perception of FDA's Breakthrough Designation

Surabhi Dangi-Garimella, PhD

A JAMA Internal Medicine study found the terms "breakthrough" and "promising" raised people's expectations on the drug's performance as opposed to when the drugs were described as having met the breakthrough criteria.

September 23rd 2015

Clinton Seeks Cap on Drug Expenses, Would Let Medicare Negotiate

Mary K. Caffrey

Hillary Clinton unveiled a plan in Iowa that features a $250 per month cap on drug costs for patients with chronic conditions. This comes 2 weeks after her chief rival for the Democratic nomination, US Senator Bernie Sanders of Vermont, introduced a bill aimed at reining in drug costs. In the summer, The American Journal of Managed Care said polling showed that rising drug costs were poised to become a major issue in the 2016 campaign.

September 23rd 2015

Physicians Believe in Biosimilars but Lack Awareness, Says Report by Quantia

Surabhi Dangi-Garimella, PhD

A white paper released by QuantiaMD has identified a lack of awareness and education about biosimilars among prescribing physicians.

September 22nd 2015

Lonsurf Granted Approval for Advanced Colorectal Cancer

Surabhi Dangi-Garimella, PhD

Lonsurf (TAS-102) is an oral 2-drug combination pill that is intended for metastatic colorectal cancer patients who have failed on chemotherapy and biological therapy.

September 22nd 2015

AstraZeneca Believes Open Innovation Will Uncover Novel Anticancer Combinations

Surabhi Dangi-Garimella, PhD

AstraZeneca hopes to harness the open source platform of the DREAM challenge, releasing preclinical data to discover synergistic cancer drug combinations.

September 21st 2015

Reimbursement Challenges Persist as Oncologists Embrace Value-Based Care, ACCC Survey Finds

Surabhi Dangi-Garimella, PhD

Among other challenges faced by cancer care centers, reimbursement for providing patient-centered care services remains at the top, a survey by The Association of Community Cancer Centers found.

September 21st 2015

New FDA Nominee May Face Challenges for His Pharma Ties

Surabhi Dangi-Garimella, PhD

A report in The New York Times identifies challenges that could be raised based on Califf's past associations with the drug industry.

...

119 120 121 122 123 124 125 126 127

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions